Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies.

Galioto A, Morando F, Rosi S, Schipilliti M, Fasolato S, Magrin M, Frigo AC, Adami F, Cavallin M, Zanus G, Plebani M, Romano A, Sticca A, Cillo U, Gatta A, Angeli P.

Transpl Int. 2012 Jan;25(1):25-33. doi: 10.1111/j.1432-2277.2011.01362.x. Epub 2011 Oct 15.

2.

Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.

Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.

Am J Nephrol. 2012;35(4):365-71. doi: 10.1159/000337482. Epub 2012 Apr 2.

PMID:
22473253
3.

Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.

Zou D, An G, Zhu G, Wang J, Shi L, Meng H, Xu Y, Sui W, Deng S, Zhan F, Qiu L.

Biol Blood Marrow Transplant. 2014 Mar;20(3):319-25. doi: 10.1016/j.bbmt.2013.11.022. Epub 2013 Dec 1.

4.

[Monoclonal gammopathy of undetermined significance].

Chaïbi P, Merlin L, Thomas C, Piette F.

Ann Med Interne (Paris). 2002 Nov;153(7):459-66. Review. French.

PMID:
12598832
5.

Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.

Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.

Ann Hematol. 2002 Jul;81(7):357-61. Epub 2002 Jul 11.

PMID:
12185503
6.

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Paiva B, Vídriales MB, Rosiñol L, Martínez-López J, Mateos MV, Ocio EM, Montalbán MÁ, Cordón L, Gutiérrez NC, Corchete L, Oriol A, Terol MJ, Echeveste MA, De Paz R, De Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Granell M, Gorosquieta A, Alegre A, Orfao A, Lahuerta JJ, Bladé J, San Miguel JF; Grupo Español de MM/Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group..

Leukemia. 2013 Oct;27(10):2056-61. doi: 10.1038/leu.2013.166. Epub 2013 Jun 7. Erratum in: Leukemia. 2013 Oct;27(10):2112.

PMID:
23743858
7.
8.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
9.
10.

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.

Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group..

Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9. Review.

11.

Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.

Baldini L, Guffanti A, Cesana BM, Colombi M, Chiorboli O, Damilano I, Maiolo AT.

Blood. 1996 Feb 1;87(3):912-8.

12.

[Monoclonal gammopathies of undetermined significance].

Krizalkovicová V, Maisnar V, Pour L, Radocha J, Hájek R.

Klin Onkol. 2008;21(4):160-4. Review. Slovak.

PMID:
19102222
14.

Monoclonal gammopathy of undetermined significance (MGUS).

Kyle RA.

Baillieres Clin Haematol. 1995 Dec;8(4):761-81. Review.

PMID:
8845571
15.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group..

Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22. Review.

PMID:
20410922
16.

Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.

Lolin YI, Chow J, Wickham NW.

Am J Clin Pathol. 1996 Oct;106(4):449-56.

PMID:
8853031
17.
18.

Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.

Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.

Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28.

PMID:
19046932
19.

Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.

Bancu I, Cañas L, Juega FJ, Pérez M, Malumbres S, Bonet J, Lauzurica R.

Transplant Proc. 2015 Oct;47(8):2344-5. doi: 10.1016/j.transproceed.2015.08.023.

PMID:
26518922
20.

Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.

Grass S, Iida S, Wikowicz A, Preuss KD, Inagaki A, Shimizu K, Ziepert M, Ueda R, Pfreundschuh M.

Cancer Sci. 2011 Mar;102(3):565-8. doi: 10.1111/j.1349-7006.2010.01819.x. Epub 2011 Jan 25.

Supplemental Content

Support Center